Applovin Leads Nasdaq 100 Surges, Regeneron Trails Behind

In early trading on Wednesday, shares of Applovin emerged as the top performer within the Nasdaq 100 index, registering a gain of 9.3%. However, it is important to note that Applovin has experienced a year-to-date decline of approximately 13.0%.

On the other hand, Regeneron Pharmaceuticals suffered as the worst performer in the Nasdaq 100 during the same trading session, with a decline of 3.6%. Year to date, the company’s stock is down about 2.9%.

Additionally, T-Mobile US and Tesla saw differing fortunes today, with T-Mobile trading down by 2.8% while Tesla managed an impressive uptick of 8.5%.

VIDEO: Nasdaq 100 Movers: REGN, APP

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.